News | Remote Monitoring | February 08, 2022

VitalSight in the U.S., Hypertension Plus in the U.K., Recognized as Outstanding Health Technology at CES 2022

VitalSight is the first remote patient monitoring service from OMRON Healthcare
VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke

February 8, 2022 — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, spotlighted its new global remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and won "Best of" honors for its programs in the U.S. and the U.K. VitalSight by OMRON in the U.S. was recognized as an INSIDER "Best of" CES selection, and Hypertension Plus by OMRON in the U.K. was selected as a TWICE Picks Awards winner for the 2022 TWICEResidential Systems, and TechRadar Pro Picks Awards.

OMRON remote patient monitoring services gained attention and recognition at the world's largest innovation show as breakthrough health technologies designed to foster greater active health condition management, strengthen the patient-physician connection, and guide behavior change to reduce health risks and advance the company's mission of Going for Zero, the elimination of heart attack and stroke.
 
"VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke, and OMRON developed Hypertension Plus as the first step toward transforming chronic care in the U.K.," said Andre Van Gils, senior general manager, global sales & marketing and executive officer of OMRON Healthcare Corporation Ltd. - Japan.
 
VitalSight is the first remote patient monitoring service from OMRON Healthcare, an easy-to-use service that a physician can offer to patients with high-risk levels of hypertension. Patients receive a kit delivered to their home that includes an OMRON connected blood pressure monitor and data hub that are pre-set to securely share measurements – digitally – with the patient's physician and care team. The VitalSight data hub, which can be used at home without Wi-Fi or cellular connection, garnered attention at CES for bridging health care gaps for patients in under-resourced communities.
 
Insider recognized VitalSight by OMRON on its list of 13 most exciting health, home, and kitchen products of CES 2022The list brought together high-tech concepts and new products – unveiled at CES 2022 – that you can buy now or later in 2022. Insider cited VitalSight among the "Best of" CES as "life-saving technology" and "great technology for patients who can't see their doctor regularly because of location, finances, or mobility concerns." To see the full list, visit Insider.
 
Hypertension Plus by OMRON is providing a new way of managing hypertension for patients and connecting them to their physicians and care teams in the U.K. The service provides an app that enables patients to work remotely with their physicians to manage their conditions. Medication decisions and actions are communicated to users through the app, while automated reminders and scheduled condition management actions keep the patient engaged in treatment. Hypertension Plus by OMRON is based on the TASMINH research studies, which demonstrated that significant reductions in blood pressure can occur through remote monitoring titration – as represented in Hypertension Plus – a step up from standard care.
 
In their annual rankings, TWICE, Residential Systems, and TechRadar Pro Picks Awards honor the best and most influential consumer technology. The TWICE Picks Awards Winners 2022 were chosen based on the impact that they are expected to have on the consumer electronic and retail industries. To see the full list, visit TWICEResidential Systems, or TechRadar Pro.
 
"Our team, fully committed to our Going for Zero mission, worked diligently to create and launch our remote patient monitoring services around the world," said Van Gils. "We are fortunate to have such dedicated staff and employees who are passionate about empowering people to take charge of their heart health and saving lives. Congratulations to our team on this extraordinary effort."
To learn more about OMRON remote patient monitoring services and see announcements the company made at CES 2022, visit: https://healthcare.omron.com/ces2022.
 
In addition to showcasing the company's new remote patient monitoring services at CES 2022, OMRON presented its new OMRON Connect app, which syncs with all OMRON connected blood pressure monitors and serves as a personal heart health coach with insights into one's blood pressure readings, guidance to manage hypertension, and incentives for behavior change.
 
For more information: OmronHealthcare.com

Related Content

News | Hypertension

June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa, its flagship health equity initiative ...

Home June 28, 2024
Home
News | Hypertension

June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at ...

Home June 06, 2024
Home
News | Hypertension

May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced ...

Home May 16, 2024
Home
News | Hypertension

May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...

Home May 08, 2024
Home
News | Hypertension

April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...

Home April 01, 2024
Home
News | Hypertension

March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the ...

Home March 18, 2024
Home
News | Hypertension

February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...

Home February 27, 2024
Home
News | Hypertension

February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...

Home February 14, 2024
Home
News | Hypertension

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...

Home January 19, 2024
Home
News | Hypertension

December 13, 2023 —Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary ...

Home December 13, 2023
Home
Subscribe Now